Malta - English - Medicines Authority

baxter healthcare limited - sodium chloride; potassium chloride; magnesium chloride hexahydrate; sodium acetate trihydrate; sodium gluconate - solution for infusion - sodium chloride 5.26 g/l; potassium chloride 0.37 g/l; magnesium chloride hexahydrate 0.30 g/l; sodium acetate trihydrate 3.68 g/l; sodium gluconate 5.02 g/l - blood substitutes and perfusion solutions

United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate in 5% dextrose injection is indicated for: magnesium sulfate in 5% dextrose injection is contraindicated in patients: risk summary magnesium sulfate in 5% dextrose injection is indicated in pregnant women for the prevention of eclampsia in women with preeclampsia and the treatment of seizures and prevention of recurrent seizures in women with eclampsia. fetal, neonatal, and maternal risks are discussed throughout the labeling. clinical considerations labor or delivery: magnesium sulfate in 5% dextrose injection is not approved for the treatment of pre-term labor. administration of magnesium sulfate in 5% dextrose injection to pregnant women longer than 5 to 7 days may lead to hypocalcemia and bone abnormalities in the developing fetus, including skeletal demineralization and osteopenia [see warnings and precautions (5.1)] . the use of intravenous magnesium in pregnant women increases human milk magnesium concentrations only slightly and oral absorption of magnesium by the infant

Australia - English - Department of Health (Therapeutic Goods Administration)

usana australia pty ltd - magnesium carbonate hydrate, quantity: 261.9 mg/g (equivalent: magnesium, qty 65.6 mg/g) - powder, oral - excipient ingredients: citric acid; sodium bicarbonate; potassium bicarbonate; sodium chloride; stevia rebaudiana; flavour - helps enhance/promote general health and wellbeing ; maintain/support general health and wellbeing ; helps enhance/promote/increase absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; enhance/improve/promote/increase (state vitamin/mineral/nutrient) levels in the body ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; helps maintain/support cellular uptake of (state vitamin/mineral/nutrient) ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; maintain/support (state vitamin/mineral) within normal range ; helps enhance/promote/increase body utilisation of (state mineral/vitamin/nutrient)

Australia - English - Department of Health (Therapeutic Goods Administration)

procter & gamble australia pty ltd - magnesium carbonate hydrate, quantity: 1.32 g (equivalent: magnesium, qty 320 mg); citric acid, quantity: 5.39 g; colecalciferol, quantity: 0.01 mg - tablet, effervescent - excipient ingredients: maltodextrin; lemon oil; sorbitol; saccharin sodium; sodium cyclamate; sodium bicarbonate; maize starch; riboflavin sodium phosphate; propylene glycol; silicon dioxide; dl-alpha-tocopherol; sucrose; hydrolysed gelatin; hydrogenated soya oil; flavour - helps convert (state food) into energy ; maintain/support energy production ; maintain/support general health and wellbeing ; maintain/support healthy teeth ; maintain/support connective tissue health ; maintain/support bone health ; maintain/support (state mineral) absorption in bones ; vitamin d helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life ; maintain/support cardiovascular system health ; maintain/support heart health ; maintain/support muscle health ; maintain/support muscle function ; maintain/support nervous system health

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - passiflora incarnata, quantity: 2.5 mg (equivalent: passiflora incarnata, qty 250 mg); magnesium carbonate hydrate, quantity: 1.243 g (equivalent: magnesium, qty 320 mg) - tablet, effervescent - excipient ingredients: colloidal anhydrous silica; leucine; maltodextrin; sodium bicarbonate; macrogol 6000; betacarotene; povidone; sucralose; citric acid; chlorophyllin-copper complex; flavour - decrease/reduce/relieve muscle cramps ; traditionally used in western herbal medicine to decrease/reduce/relieve restlessness/excess nervous energy ; traditionally used in western herbal medicine to decrease/reduce/relieve symptoms of stress (linked indication:decrease/reduce/relieve sleeplessness)

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - potassium chloride, quantity: 0.3 g/l; magnesium chloride hexahydrate, quantity: 0.3 g/l; sodium chloride, quantity: 6.02 g/l; sodium acetate trihydrate, quantity: 4.63 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - ionolyte is indicated for:,- mild metabolic acidosis,- as a source of water and electrolytes

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - potassium chloride, quantity: 0.3 g/l; magnesium chloride hexahydrate, quantity: 0.3 g/l; sodium chloride, quantity: 6.02 g/l; sodium acetate trihydrate, quantity: 4.63 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - ionolyte is indicated for:,- mild metabolic acidosis,- as a source of water and electrolytes

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia.  in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

United States - English - NLM (National Library of Medicine)

medical purchasing solutions, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia.  in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in a pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

United States - English - NLM (National Library of Medicine)

medical purchasing solutions, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia.  in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in a pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.